Uterine fibroids and current clinical challenges

Area of Science:

• Gynecological oncology
• Pharmacology
• Tumor biology

Background:

• Uterine fibroids (UF) are the most common gynecological tumors affecting premenopausal women.
• Hysterectomy is the primary treatment, with minimally invasive techniques offering advantages over laparotomy.
• Current drug therapies for UF are largely unsatisfactory due to limited efficacy.

Purpose of the Study:

• To highlight the limitations of current UF drug therapies.
• To advocate for the development of novel therapeutic agents for UF.
• To propose multi-target drugs as a superior strategy for UF treatment.

Main Methods:

• Review of current therapeutic options for UF.
• Analysis of the limitations of single-target drug pathways (estrogen and progesterone).
• Conceptualization of multi-target drug strategies for UF.

Main Results:

• Current single-target drugs for UF exhibit limited therapeutic effects.
• Multi-target drugs have the potential to address the complexity of UF pathogenesis.
• Simultaneous modulation of multiple signaling pathways is proposed for robust UF treatment.

Conclusions:

• Novel drug development for UF is essential.
• Multi-target drugs are a promising avenue for achieving more effective and durable UF treatment.
• Targeting multiple critical hubs in UF signaling pathways could overcome limitations of current therapies.